{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:45:25Z","timestamp":1793148325637,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11916-019-0800-2","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T06:43:26Z","timestamp":1564037006000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Advances in the Understanding and Management of Chronic Pain in Multiple Sclerosis: a Comprehensive Review"],"prefix":"10.1007","volume":"23","author":[{"given":"Ivan","family":"Urits","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Adamian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Fiocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Hoyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Viswanath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,25]]},"reference":[{"key":"800_CR1","first-page":"1","volume":"19","author":"N Ghasemi","year":"2017","unstructured":"Ghasemi N, Razavi S, Nikzad E. Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy. Cell J. 2017;19:1\u201310.","journal-title":"Cell J"},{"key":"800_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jneuroim.2017.11.012","volume":"314","author":"F Monteleone","year":"2018","unstructured":"Monteleone F, Nicoletti CG, Stampanoni Bassi M, Iezzi E, Buttari F, Furlan R, et al. Nerve growth factor is elevated in the CSF of patients with multiple sclerosis and central neuropathic pain. J Neuroimmunol. 2018;314:89\u201393.","journal-title":"J Neuroimmunol"},{"key":"800_CR3","first-page":"244","volume":"9","author":"S Shahrbanian","year":"2018","unstructured":"Shahrbanian S, Duquette P, Mayo NE. Impairment, disability and fatigue in multiple sclerosis. Casp J Intern Med. 2018;9:244\u201351.","journal-title":"Casp J Intern Med"},{"key":"800_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10072-017-3217-x","volume":"39","author":"D Ferraro","year":"2018","unstructured":"Ferraro D, Plantone D, Morselli F, Dallari G, Simone AM, Vitetta F, et al. Systematic assessment and characterization of chronic pain in multiple sclerosis patients. Neurol Sci Neurol Sci. 2018;39:445\u201353.","journal-title":"Neurol Sci Neurol Sci"},{"key":"800_CR5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s11136-014-0804-7","volume":"24","author":"S Shahrbanian","year":"2015","unstructured":"Shahrbanian S, Duquette P, Kuspinar A, Mayo NE. Contribution of symptom clusters to multiple sclerosis consequences. Qual Life Res. 2015;24:617\u201329.","journal-title":"Qual Life Res"},{"key":"800_CR6","first-page":"205521731772830","volume":"3","author":"R Green","year":"2017","unstructured":"Green R, Cutter G, Friendly M, Kister I. Which symptoms contribute the most to patients\u2019 perception of health in multiple sclerosis? Mult Scler J Exp Transl Clin. 2017;3:205521731772830.","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"800_CR7","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.autrev.2017.07.004","volume":"16","author":"R Patejdl","year":"2017","unstructured":"Patejdl R, Zettl UK. Spasticity in multiple sclerosis: contribution of inflammation, autoimmune mediated neuronal damage and therapeutic interventions. Autoimmun Rev Elsevier BV. 2017;16:925\u201336.","journal-title":"Autoimmun Rev"},{"key":"800_CR8","first-page":"3","volume":"29","author":"H Gilmour","year":"2018","unstructured":"Gilmour H, Ramage-Morin PL, Wong SL. Multiple sclerosis: prevalence and impact. Heal Rep. 2018;29:3\u20138.","journal-title":"Heal Rep"},{"key":"800_CR9","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/ana.25247","volume":"83","author":"G Disanto","year":"2018","unstructured":"Disanto G, Zecca C, MacLachlan S, Sacco R, Handunnetthi L, Meier UC, et al. Prodromal symptoms of multiple sclerosis in primary care. Ann Neurol. 2018;83:1162\u201373.","journal-title":"Ann Neurol"},{"key":"800_CR10","doi-asserted-by":"crossref","unstructured":"Zhang Y, Taylor B V., Simpson S, Blizzard L, van der Mei I. Patient-reported outcomes are worse for progressive-onset multiple sclerosis than relapse-onset multiple sclerosis, particularly early in the disease process. Eur J Neurol. 2018;1\u20137.","DOI":"10.1111\/ene.13786"},{"issue":"2","key":"800_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s40263-018-0489-5","volume":"32","author":"Claudio Solaro","year":"2018","unstructured":"\u2022 Solaro C, Gamberini G, Masuccio FG. Depression in multiple sclerosis: epidemiology, aetiology, diagnosis and treatment. CNS Drugs Springer International Publishing. 2018;32:117\u201333. An important investigation of depression in patients with multiple sclerosis.","journal-title":"CNS Drugs"},{"key":"800_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00415-017-8676-8","volume":"265","author":"D Conradsson","year":"2017","unstructured":"Conradsson D, Ytterberg C, von Koch L, Johansson S. Changes in disability in people with multiple sclerosis: a 10-year prospective study. J Neurol. Springer Berlin Heidelberg. 2017;265:119\u201326.","journal-title":"J Neurol"},{"key":"800_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1191\/1352458505ms1168oa","volume":"11","author":"LV Kalia","year":"2005","unstructured":"Kalia LV, OConnor PW. Severity of chronic pain and its relationship to quality of life in multiple sclerosis. Mult Scler J. Sage PublicationsSage CA: Thousand Oaks, CA. 2005;11:322\u20137.","journal-title":"Mult Scler J"},{"key":"800_CR14","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.clinthera.2006.04.005","volume":"28","author":"HJ Crayton","year":"2006","unstructured":"Crayton HJ, Rossman HS. Managing the symptoms of multiple sclerosis: a multimodal approach. Clin TherElsevier. 2006;28:445\u201360.","journal-title":"Clin Ther"},{"key":"800_CR15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.sjpain.2017.04.070","volume":"16","author":"J Young","year":"2017","unstructured":"Young J, Amatya B, Galea MP, Khan F. Chronic pain in multiple sclerosis: a 10-year longitudinal study. Scand J Pain No longer published by Elsevier. 2017;16:198\u2013203.","journal-title":"Scand J Pain"},{"key":"800_CR16","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1212\/01.CON.0000433284.07844.6b","volume":"19","author":"RA Marrie","year":"2013","unstructured":"Marrie RA, Hanwell H. General health issues in multiple sclerosis. Contin Lifelong Learn Neurol. 2013;19:1046\u201357.","journal-title":"Contin Lifelong Learn Neurol"},{"key":"800_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1037\/rep0000027","volume":"60","author":"D Amtmann","year":"2015","unstructured":"Amtmann D, Askew RL, Kim J, Chung H, Ehde DM, Bombardier CH, et al. Pain affects depression through anxiety, fatigue, and sleep in multiple sclerosis. Rehabil Psychol. 2015;60:81\u201390.","journal-title":"Rehabil Psychol"},{"key":"800_CR18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jpsychores.2005.06.001","volume":"59","author":"LA Chwastiak","year":"2005","unstructured":"Chwastiak LA, Gibbons LE, Ehde DM, Sullivan M, Bowen JD, Bombardier CH, et al. Fatigue and psychiatric illness in a large community sample of persons with multiple sclerosis. J Psychosom Res. 2005;59:291\u20138.","journal-title":"J Psychosom Res"},{"key":"800_CR19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2147\/JPR.S146717","volume":"11","author":"R Scherder","year":"2018","unstructured":"Scherder R, Kant N, Wolf ET, Pijnenburg B, Scherder EJ. Psychiatric and physical comorbidities and pain in patients with multiple sclerosis. J Pain Res Dove Press. 2018;11:325\u201334.","journal-title":"J Pain Res"},{"key":"800_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/AJP.0000000000000092","volume":"31","author":"PH Finan","year":"2015","unstructured":"Finan PH, Garland EL. The role of positive affect in pain and its treatment. Clin J Pain. 2015;31:177\u201387.","journal-title":"Clin J Pain"},{"key":"800_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/1924174","volume":"2018","author":"Rogier J. Scherder","year":"2018","unstructured":"\u2022 Scherder RJ, Kant N, Wolf ET, Pijnenburg BCM, Scherder EJA. Sensory function and chronic pain in multiple sclerosis. Pain Res Manag Hindawi. 2018;2018:1\u20139. Differnces of sensory function in patients with MS.","journal-title":"Pain Research and Management"},{"key":"800_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fneur.2017.00461","volume":"8","author":"CH Marck","year":"2017","unstructured":"Marck CH, De Livera AM, Weiland TJ, Jelinek PL, Neate SL, Brown CR, et al. Pain in people with multiple sclerosis: associations with modifiable lifestyle factors, fatigue, depression, anxiety, and mental health quality of life. Front Neurol. 2017;8:461.","journal-title":"Front Neurol"},{"key":"800_CR23","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1037\/hea0000611","volume":"37","author":"A Arewasikporn","year":"2018","unstructured":"Arewasikporn A, Turner AP, Alschuler KN, Hughes AJ, Ehde DM. Cognitive and affective mechanisms of pain and fatigue in multiple sclerosis. Health Psychol. 2018;37:544\u201352.","journal-title":"Health Psychol"},{"key":"800_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.7224\/1537-2073.2016-076","volume":"20","author":"A Senders","year":"2018","unstructured":"Senders A, Borgatti A, Hanes D, Shinto L. Association between pain and mindfulness in multiple sclerosis: a cross-sectional survey. Int J MS Care The Consortium of Multiple Sclerosis Centers. 2018;20:28\u201334.","journal-title":"Int J MS Care"},{"key":"800_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11916-016-0594-4","volume":"20","author":"A Mazhari","year":"2016","unstructured":"Mazhari A. Multiple sclerosis-related pain syndromes: an imaging update. Curr Pain Headache Rep Springer US. 2016;20:63.","journal-title":"Curr Pain Headache Rep"},{"key":"800_CR26","doi-asserted-by":"publisher","first-page":"a028969","DOI":"10.1101\/cshperspect.a028969","volume":"8","author":"CC Hemond","year":"2018","unstructured":"Hemond CC, Bakshi R. Magnetic resonance imaging in multiple sclerosis. Cold Spring Harb Perspect Med. Cold Spring Harbor Laboratory Press. 2018;8:a028969.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"800_CR27","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.annfar.2010.08.004","volume":"29","author":"S Sigaut","year":"2010","unstructured":"Sigaut S, Merckx P, Peuch C, Necib S, Pingeon F, Mantz J. Does an educational strategy based on systematic preoperative assessment of simplified Apfel\u2019s score decrease postoperative nausea and vomiting? Ann Fr Anesth Reanim. 2010;29:765\u20139.","journal-title":"Ann Fr Anesth Reanim"},{"key":"800_CR28","doi-asserted-by":"publisher","first-page":"e005718","DOI":"10.1136\/bmjopen-2014-005718","volume":"4","author":"M Ploughman","year":"2014","unstructured":"Ploughman M, Beaulieu S, Harris C, Hogan S, Manning OJ, Alderdice PW, et al. The Canadian survey of health, lifestyle and ageing with multiple sclerosis: methodology and initial results. BMJ Open. 2014;4:e005718.","journal-title":"BMJ Open"},{"key":"800_CR29","doi-asserted-by":"publisher","first-page":"240","DOI":"10.7224\/1537-2073.2016-065","volume":"19","author":"A Fallata","year":"2017","unstructured":"Fallata A, Salter A, Tyry T, Cutter G, Marrie RA. Trigeminal neuralgia commonly precedes the diagnosis of multiple sclerosis. Int J MS Care. 2017;19:240\u20136.","journal-title":"Int J MS Care"},{"key":"800_CR30","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.wneu.2017.12.147","volume":"111","author":"J Zakrzewska","year":"2018","unstructured":"Zakrzewska J, Wu J, Brathwaite T. A systematic review of the management of trigeminal neuralgia in patients with multiple sclerosis. World Neurosurg. 2018;111:291\u2013306.","journal-title":"World Neurosurg"},{"key":"800_CR31","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1212\/WNL.45.6.1097","volume":"45","author":"A Reder","year":"1995","unstructured":"Reder A, Amason B. Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue. Neurology. 1995;45:1097\u2013100.","journal-title":"Neurology"},{"key":"800_CR32","doi-asserted-by":"crossref","unstructured":"Xu Z, Mathieu D, Heroux F, Abbassy M, Barnett G, Mohammadi A, et al. Stereotactic radiosurgery for trigeminal neuralgia in patients with multiple sclerosis: a multicenter study. Neurosurgery. 2018;0.","DOI":"10.1093\/neuros\/nyy142"},{"key":"800_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.clineuro.2016.01.017","volume":"143","author":"S Sahai-Srivastava","year":"2016","unstructured":"Sahai-Srivastava S, Wang SL, Ugurlu C, Amezcua L. Headaches in multiple sclerosis: cross-sectional study of a multiethnic population. Clin Neurol Neurosurg. 2016;143:71\u20135.","journal-title":"Clin Neurol Neurosurg"},{"key":"800_CR34","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1007\/s10072-015-2146-9","volume":"36","author":"L Mantia","year":"2015","unstructured":"Mantia L, Prone V. Headache in multiple sclerosis and autoimmune disorders. Neurol Sci. 2015;36:S75\u20138.","journal-title":"Neurol Sci"},{"key":"800_CR35","first-page":"1","volume":"15","author":"M Togha","year":"2016","unstructured":"Togha M, Khoshsirat NA, Moghadasi AN, Mousavinia F, Mozafari M, Neishaboury M, et al. Headache in relapse and remission phases of multiple sclerosis: a case-control study. Iran J Neurol. 2016;15:1\u20138.","journal-title":"Iran J Neurol"},{"key":"800_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11940-018-0495-4","volume":"20","author":"F Husain","year":"2018","unstructured":"Husain F, Pardo G, Rabadi M. Headache and its management in patients with multiple sclerosis. Curr Treat Options Neurol. 2018;20:10.","journal-title":"Curr Treat Options Neurol"},{"key":"800_CR37","doi-asserted-by":"publisher","first-page":"e00852","DOI":"10.1002\/brb3.852","volume":"7","author":"M Gebhardt","year":"2017","unstructured":"Gebhardt M, Kropp P, J\u00fcrgens TP, Hoffmann F, Zettl UK. Headache in the first manifestation of multiple sclerosis \u2013 prospective, multicenter study. Brain Behav. 2017;7:e00852.","journal-title":"Brain Behav"},{"key":"800_CR38","first-page":"1","volume":"2","author":"M Gustavsen","year":"2016","unstructured":"Gustavsen M, Celius E, Winsvold B, Moen S, Nygaard G, Berg-Hansen P, et al. Migraine and frequent tension-type headache are not associated with multiple sclerosis in a Norwegian case-control study. Mult Scler J Exp Transl Clin. 2016;2:1\u20134.","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"800_CR39","doi-asserted-by":"publisher","first-page":"A83","DOI":"10.1186\/1129-2377-16-S1-A83","volume":"16","author":"R Terlizzi","year":"2015","unstructured":"Terlizzi R, Merli E, Buccellato E, Giannini G, Favoni V, Pierangeli G, et al. Headache in multiple sclerosis: prevalence and clinical features in a case control-study. J Headache Pain. 2015;16:A83.","journal-title":"J Headache Pain"},{"key":"800_CR40","doi-asserted-by":"publisher","first-page":"e0191534","DOI":"10.1371\/journal.pone.0191534","volume":"13","author":"CB Beggs","year":"2018","unstructured":"Beggs CB, Giaquinta A, Veroux M, De Marco E, Mociskyte D, Veroux P. Mid-term sustained relief from headaches after balloon angioplasty of the internal jugular veins in patients with multiple sclerosis. PLoS One. 2018;13:e0191534.","journal-title":"PLoS One"},{"key":"800_CR41","doi-asserted-by":"crossref","unstructured":"Murphey KL, Bethea JR, Fischer R. Neuropathic pain in multiple sclerosis\u2014current therapeutic intervention and future treatment perspectives. Mult Scler Perspect Treat Pathog. 2017;53\u201369.","DOI":"10.15586\/codon.multiplesclerosis.2017.ch4"},{"key":"800_CR42","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1177\/1352458515613643","volume":"22","author":"H Heitmann","year":"2016","unstructured":"Heitmann H, Biberacher V, Tiemann L, Buck D, Loleit V, Selter RC, et al. Prevalence of neuropathic pain in early multiple sclerosis. Mult Scler J. 2016;22:1224\u201330.","journal-title":"Mult Scler J"},{"key":"800_CR43","doi-asserted-by":"crossref","unstructured":"Khan A, Kamran S, Ponirakis G, Akhtar N, Khan R, George P, et al. Peripheral neuropathy in patients with multiple sclerosis. PLoS One. 2018.","DOI":"10.1371\/journal.pone.0193270"},{"key":"800_CR44","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1007\/s00415-018-8758-2","volume":"265","author":"C Solaro","year":"2018","unstructured":"Solaro C, Cella M, Signori A, Martinelli V, Radaelli M, Centonze D, et al. Identifying neuropathic pain in patients with multiple sclerosis: a cross-sectional multicenter study using highly specific criteria. J Neurol. 2018;265:828\u201335.","journal-title":"J Neurol"},{"key":"800_CR45","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/phar.2086","volume":"38","author":"DK Patten","year":"2018","unstructured":"Patten DK, Schultz BG, Berlau DJ. The safety and efficacy of low-dose naltrexone in the management of chronic pain and inflammation in multiple sclerosis, fibromyalgia, Crohn\u2019s disease, and other chronic pain disorders. Pharmacotherapy. 2018;38:382\u20139.","journal-title":"Pharmacotherapy"},{"key":"800_CR46","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/S0140-6736(03)14738-1","volume":"362","author":"J Zajicek","year":"2003","unstructured":"Zajicek J, Fox P, Sanders H, Wright D, Vickery J, Nunn A, et al. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet Elsevier. 2003;362:1517\u201326.","journal-title":"Lancet"},{"key":"800_CR47","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1213\/ane.0b013e31819e431f","volume":"108","author":"TJ Gan","year":"2009","unstructured":"Gan TJ, Sinha AC, Kovac AL, Jones RK, Cohen SA, Battikha JP, et al. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting. Anesth Analg. 2009;108:1498\u2013504.","journal-title":"Anesth Analg"},{"key":"800_CR48","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11910-018-0859-x","volume":"18","author":"J Rice","year":"2018","unstructured":"Rice J, Cameron M. Cannabinoids for treatment of MS symptoms: state of the evidence. Curr Neurol Neurosci Rep. 2018;18:50.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"800_CR49","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3389\/fneur.2018.00183","volume":"9","author":"T Rudroff","year":"2018","unstructured":"Rudroff T, Sosnoff J. Cannabidiol to improve mobility in people with multiple sclerosis. Front Neurol Frontiers Media SA. 2018;9:183.","journal-title":"Front Neurol"},{"key":"800_CR50","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/medicines5030059","volume":"5","author":"M Turri","year":"2018","unstructured":"Turri M, Teatini F, Donato F, Zanette G, Tugnoli V, Deotto L, et al. Pain modulation after oromucosal cannabinoid spray (SATIVEX\u00ae) in patients with multiple sclerosis: a study with quantitative sensory testing and laser-evoked potentials. Medicines. 2018;5:59.","journal-title":"Medicines"},{"key":"800_CR51","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1097\/j.pain.0000000000001293","volume":"159","author":"E Stockings","year":"2018","unstructured":"Stockings E, Campbell G, Hall WD, Nielsen S, Zagic D, Rahman R, et al. Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions. Pain. 2018;159:1932\u201354.","journal-title":"Pain"},{"key":"800_CR52","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11910-018-0814-x","volume":"18","author":"S Nielsen","year":"2018","unstructured":"Nielsen S, Germanos R, Weier M, Pollard J, Degenhardt L, Hall W, et al. The use of cannabis and cannabinoids in treating symptoms of multiple sclerosis: a systematic review of reviews. Curr Neurol Neurosci Rep. 2018;18:8.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"800_CR53","unstructured":"Amato L, Minozzi S, Mitrova Z, Parmelli E, Saulle R, Cruciani F, et al. Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy. Epidemiol Prev. 41:279\u201393."},{"key":"800_CR54","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5507\/bp.2018.007","volume":"162","author":"L Landa","year":"2018","unstructured":"Landa L, Jurica J, Sliva J, Pechackova M, Demlova R. Medical cannabis in the treatment of cancer pain and spastic conditions and options of drug delivery in clinical practice. Biomed Pap. 2018;162:18\u201325.","journal-title":"Biomed Pap"},{"key":"800_CR55","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11481-015-9600-6","volume":"10","author":"ME Lynch","year":"2015","unstructured":"Lynch ME, Ware MA. Cannabinoids for the treatment of chronic non-cancer pain: an updated systematic review of randomized controlled trials. J NeuroImmune Pharmacol. 2015;10:293\u2013301.","journal-title":"J NeuroImmune Pharmacol"},{"key":"800_CR56","doi-asserted-by":"crossref","unstructured":"Jitpakdee T, Mandee S. Strategies for preventing side effects of systemic opioid in postoperative pediatric patients. 2014.","DOI":"10.1111\/pan.12420"},{"issue":"5","key":"800_CR57","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1179\/016164109X12590518685660","volume":"32","author":"C. Collin","year":"2010","unstructured":"Collin C, Ehler E, Waberzinek G, Alsindi Z, Davies P, Powell K, et al. A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis. Taylor & Francis; 2013. https:\/\/doi.org\/10.1179\/016164109X12590518685660 .","journal-title":"Neurological Research"},{"key":"800_CR58","doi-asserted-by":"crossref","unstructured":"Demaneuf T, Aitken Z, Karahalios A, Leong TI, De Livera A, Jelinek G, et al. The effectiveness of exercise interventions for pain reduction in people with multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials. Arch Phys Med Rehabil. 2018.","DOI":"10.1016\/j.apmr.2018.08.178"},{"key":"800_CR59","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.explore.2017.07.006","volume":"14","author":"T Kahraman","year":"2018","unstructured":"Kahraman T, Ozdogar AT, Yigit P, Hosgel I, Mehdiyev Z, Ertekin O, et al. Feasibility of a 6-month yoga program to improve the physical and psychosocial status of persons with multiple sclerosis and their family members. Explore. 2018;14:36\u201343.","journal-title":"Explore."},{"key":"800_CR60","doi-asserted-by":"crossref","unstructured":"Halabchi F, Alizadeh Z, Sahraian M, Abolhasani M. Exercise prescription for patients with multiple sclerosis; potential benefits and practical recommendations. BioMed Cent Neurol. 2017;17.","DOI":"10.1186\/s12883-017-0960-9"},{"key":"800_CR61","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S1474-4422(17)30281-8","volume":"16","author":"R Motl","year":"2017","unstructured":"Motl R, Sandroff B, Kwakkel G, Dalgas U, Feinstein A, Heesen C, et al. Exercise in patients with multiple sclerosis. Lancet Neurol. 2017;16:848\u201356.","journal-title":"Lancet Neurol"},{"key":"800_CR62","doi-asserted-by":"crossref","unstructured":"Ryan J, Fortune J, Stennett A, Kilbride C, Anokye N, Victor C, et al. Changing physical activity behaviour for people with multiple sclerosis: protocol of a randomised controlled feasibility trial (iStep-MS). Br Med J Open. 2017;7.","DOI":"10.1136\/bmjopen-2017-018875"},{"key":"800_CR63","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.cct.2018.05.016","volume":"71","author":"J Rimmer","year":"2018","unstructured":"Rimmer J, Thirumalai M, Young H, Pekmezi D, Tracy T, Riser E, et al. Rationale and design of the tele-exercise and multiple sclerosis (TEAMS) study: a comparative effectiveness trial between a clinic- and home-based telerehabilitation intervention for adults with multiple sclerosis (MS) living in the deep south. Contemp Clin Trials. 2018;71:186\u201393.","journal-title":"Contemp Clin Trials"},{"key":"800_CR64","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1177\/1352458517736150","volume":"23","author":"H Abboud","year":"2017","unstructured":"Abboud H, Hill E, Siddiqui J, Serra A, Walter B. Neuromodulation in multiple sclerosis. Mult Scler. 2017;23:1663\u201376.","journal-title":"Mult Scler"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-019-0800-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11916-019-0800-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-019-0800-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T09:49:05Z","timestamp":1721555345000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11916-019-0800-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,25]]},"references-count":64,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["800"],"URL":"https:\/\/doi.org\/10.1007\/s11916-019-0800-2","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,25]]},"assertion":[{"value":"25 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Ivan Urits, Leena Adamian, Jacob Fiocchi, Dylan Hoyt, Carly Ernst, and Omar Viswanath declare no conflict of interest. Alan D. Kaye discloses that he is on the Speakers Bureau for Depomed, Inc. and Merck.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"59"}}